ArticleJournal of experimental orthopaedics2025
Evaluation of centre-specific machine learning models in predicting 2-year outcomes of hip arthroscopy for mixed femoracetabular impingement syndrome.
Article in Journal of experimental orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Age and intraoperative cartilage status as determinants of mid-term functional outcomes after hip arthroscopy.Journal of experimental orthopaedics · 2026Article
- Evaluation of centre-specific machine learning models in predicting 2-year outcomes of hip arthroscopy for mixed femoracetabular impingement syndrome.Journal of experimental orthopaedics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To construct a centre-specific machine learning (ML) prediction model based on preoperative factors. It was hypothesised that the ML prediction model would accurately predict whether patient-reported outcome scores (PROs) over at least 2 years would reach the minimal clinically important difference (MCID). Methods: A retrospective analysis was performed on mixed-type femoroacetabular impingement syndrome (FAIS) patients who had hip arthroscopy at our institution between 2016 and 2018. The primary outcome was the rate of achieving MCID in PROs assessed at least 2 years after surgery, PROs included the hip outcome score-activities of daily living (HOS-ADL), modified Harris Hip Score (mHHS), visual analogue scale (VAS) for pain and international hip outcome tool-12 (iHOT-12), assessed at a minimum of 2 years postoperatively. Preoperative patient features were selected using the least absolute shrinkage and selection operator (LASSO) algorithm. Three ML models were constructed using balanced sample data and optimal feature subsets: logistic regression (LR), support vector machine (SVM) and random forest (RF). Model performance was assessed using the area under the receiver operating characteristic curve (AUROC) and the concordance index (C-index). Model interpretations were conducted using the SHapley Additive explanation (SHAP) method. Results: A total of 210 patients (48.1% female) were included. The LR, SVM, RF models had AUROC 0.76 (0.61-0.83), 0.89 (0.80-0.94), 0.99 (0.98-1.00), respectively, and C-index 0.74 (0.65-0.82), 0.86 (0.81-0.90), 0.95 (0.93-0.96), respectively. Preoperative symptom duration, preoperative HOS-ADL, hip joint space and preoperative alpha angle were identified as the most important predictors. Conclusion: Among the three ML prediction models, RF performed best in predicting whether PROs reached MCID, demonstrating excellent discriminative ability, calibration and robustness. This indicates that individualised and robust ML prediction models for outcome prediction based on preoperative factors are feasible even with limited amounts of centre-specific data. Level of Evidence: Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.